Consistent with the trends observed in the 49 cases overall, we found that ZNF32 expression was positively correlated with LC3 II expression in both subtypes of breast cancer samples (Fig. 5F luminal A subtype and Fig. 5G luminal B phenotype). The gene discussed is ZNF32; the disease is breast cancer.